NWBO has taken 16 years to complete a Phase 3 trial. 19 months to analyze the trial data. NWBO moves very slowly in moving ahead. To complete an FDA application will be a challenge with all the Phase 3 trial issues they have to deal with. Doubt it will move forward very quickly. All while burning more shareholder cash.
Take all the experts you claim are "extremely impressed" and that means nothing for the share price (down ~50% 52 weeks and AFTER the TLD), and nothing for regulator approval. The investment community is clearly not impressed with the TLD data. Will be interested to see what FDA says about this heavily manipulated trial.
Market Data 
Markets 
AI
